{
    "date": "2022\/1\/8 19:00",
    "data": {
        "専門家3行コメント": [
            {
                "@ja": "新規陽性者数の増加比が著しく上昇し、これまでに経験したことのない高い水準になった。変異株（デルタ株）から変異株（オミクロン株）への置き換わりによる、急速な感染拡大に警戒する必要がある。",
                "@en": "The increase rate of new positive cases has risen significantly, reaching a record high. There is the need to be vigilant against a rapid resurgence of infections due to the replacement of the Delta variant by the Omicron variant."
            },
            {
                "@ja": "変異株（オミクロン株）の急速な感染拡大に備え、海外の感染状況を踏まえ、感染者の基礎疾患、重症度、年齢構成などを把握、分析しながら入院医療、宿泊及び自宅療養の計画を前倒しする必要がある。",
                "@en": "To prepare against a rapid spread infections caused by the Omicron variant, there is the need to take into consideration the infection situation overseas and accelerate plans for hospital care, designated hotels for recovery, and at-home recovery, while grasping and analyzing the characteristics of patients, including underlying conditions, severity of illness, and age. "
            }
        ],
        "(1)新規陽性者数": 502.1,
        "(2)#7119（東京消防庁救急相談センター）における発熱等相談件数 ": 77.4,
        "(3)新規陽性者における接触歴等不明者（人数）": 326.7,
        "(3)新規陽性者における接触歴等不明者（増加比）": 883,
        "(4)PCR・抗原検査（陽性率）": 5.8,
        "(4)PCR・抗原検査（検査人数）": 7025.3,
        "(5)救急医療の東京ルールの適用件数": 69.9,
        "(6)入院患者数": 659,
        "(6)入院患者確保病床数": 4839,
        "(7)重症患者数": 4,
        "(7)重症患者確保病床数": 353,
        "総括コメント-感染状況": {
            "date": "2022-01-06",
            "level": 2,
            "display": {
                "@ja": "感染拡大の兆候があると思われる",
                "@en": "There are signs that the infection will spread. "
            }
        },
        "総括コメント-医療提供体制": {
            "date": "2022-01-06",
            "level": 1,
            "display": {
                "@ja": "通常の医療との両立が安定的に可能な状況である",
                "@en": "A balance between the provision of COVID and non-COVID health care is firmly possible."
            }
        }
    }
}